219 related articles for article (PubMed ID: 33114431)
21. Monocyte CD163 is altered in association with diabetic complications: possible protective role.
Min D; Brooks B; Wong J; Aamidor S; Seehoo R; Sutanto S; Harrisberg B; Yue DK; Twigg SM; McLennan SV
J Leukoc Biol; 2016 Dec; 100(6):1375-1383. PubMed ID: 27354410
[TBL] [Abstract][Full Text] [Related]
22. DNA polymorphisms in the controlling region of the human haptoglobin genes: a molecular explanation for the haptoglobin 2-1 modified phenotype.
Maeda N
Am J Hum Genet; 1991 Jul; 49(1):158-66. PubMed ID: 2063867
[TBL] [Abstract][Full Text] [Related]
23. Haptoglobin polymorphism in relation to antioxidative enzymes activity in type 2 diabetes mellitus.
Awadallah SM; Ramadan AR; Nusier MK
Diabetes Metab Syndr; 2013; 7(1):26-31. PubMed ID: 23517792
[TBL] [Abstract][Full Text] [Related]
24. [Clinical and biological features of haptoglobin phenotypes].
Simon A; Schneider N; Gillery P; Oudart JB
Ann Biol Clin (Paris); 2020 Oct; 78(5):493-498. PubMed ID: 33026345
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory markers and haptoglobin polymorphism in Saudi with non-insulin-dependent diabetes mellitus.
Mohieldein A; Alzohairy M; Hasan M; Khan AA
Glob J Health Sci; 2012 Nov; 5(1):135-42. PubMed ID: 23283045
[TBL] [Abstract][Full Text] [Related]
26. The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.
Dalan R; Liuh Ling G
Eur J Prev Cardiol; 2018 Sep; 25(14):1502-1519. PubMed ID: 29799294
[TBL] [Abstract][Full Text] [Related]
27. Soluble macrophage-derived CD163: a homogenous ectodomain protein with a dissociable haptoglobin-hemoglobin binding.
Møller HJ; Nielsen MJ; Maniecki MB; Madsen M; Moestrup SK
Immunobiology; 2010 May; 215(5):406-12. PubMed ID: 19581020
[TBL] [Abstract][Full Text] [Related]
28. The haptoglobin beta subunit sequesters HMGB1 toxicity in sterile and infectious inflammation.
Yang H; Wang H; Wang Y; Addorisio M; Li J; Postiglione MJ; Chavan SS; Al-Abed Y; Antoine DJ; Andersson U; Tracey KJ
J Intern Med; 2017 Jul; 282(1):76-93. PubMed ID: 28464519
[TBL] [Abstract][Full Text] [Related]
29. Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohort.
Deichgræber P; Witte DR; Møller HJ; Skriver MV; Richelsen B; Jørgensen ME; Johansen NB; Sandbæk A
Diabetologia; 2016 Nov; 59(11):2467-2476. PubMed ID: 27541014
[TBL] [Abstract][Full Text] [Related]
30. Soluble CD163 levels are elevated in cerebrospinal fluid and serum in people with Type 2 diabetes mellitus and are associated with impaired peripheral nerve function.
Kallestrup M; Møller HJ; Tankisi H; Andersen H
Diabet Med; 2015 Jan; 32(1):54-61. PubMed ID: 25156085
[TBL] [Abstract][Full Text] [Related]
31. Haptoglobin phenotype 2-2 as a potentially new risk factor for spontaneous venous thromboembolism.
Vormittag R; Vukovich T; Mannhalter C; Minar E; Schönauer V; Bialonczyk C; Hirschl M; Pabinger I
Haematologica; 2005 Nov; 90(11):1557-61. PubMed ID: 16266904
[TBL] [Abstract][Full Text] [Related]
32. The haptoglobin-gene deletion responsible for anhaptoglobinemia.
Koda Y; Soejima M; Yoshioka N; Kimura H
Am J Hum Genet; 1998 Feb; 62(2):245-52. PubMed ID: 9463309
[TBL] [Abstract][Full Text] [Related]
33. Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio.
Moreno JA; Dejouvencel T; Labreuche J; Smadja DM; Dussiot M; Martin-Ventura JL; Egido J; Gaussem P; Emmerich J; Michel JB; Blanco-Colio LM; Meilhac O
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1253-62. PubMed ID: 20299688
[TBL] [Abstract][Full Text] [Related]
34. The relationship between haptoglobin polymorphism and serum ceruloplasmin ferroxidase activity.
Janaydeh M; Hamad M; Awadallah S
Clin Exp Med; 2004 Apr; 3(4):219-23. PubMed ID: 15103512
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic polymorphism of haptoglobin: a novel risk factor for the development of infection in liver cirrhosis.
Vitalis Z; Altorjay I; Tornai I; Palatka K; Kacska S; Palyu E; Tornai D; Udvardy M; Harsfalvi J; Dinya T; Veres G; Lakatos PL; Papp M
Hum Immunol; 2011 Apr; 72(4):348-54. PubMed ID: 21262313
[TBL] [Abstract][Full Text] [Related]
36. Haptoglobin polymorphism: a novel genetic risk factor for celiac disease development and its clinical manifestations.
Papp M; Foldi I; Nemes E; Udvardy M; Harsfalvi J; Altorjay I; Mate I; Dinya T; Varvolgyi C; Barta Z; Veres G; Lakatos PL; Tumpek J; Toth L; Szathmari E; Kapitany A; Gyetvai A; Korponay-Szabo IR
Clin Chem; 2008 Apr; 54(4):697-704. PubMed ID: 18258668
[TBL] [Abstract][Full Text] [Related]
37. Serum levels of soluble CD163 as a specific marker of macrophage/monocyte activity in sarcoidosis patients.
Tanimura H; Mizuno K; Okamoto H
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):99-105. PubMed ID: 26278688
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype: implications for the response to intraplaque hemorrhage and plaque vulnerability.
Levy AP; Purushothaman KR; Levy NS; Purushothaman M; Strauss M; Asleh R; Marsh S; Cohen O; Moestrup SK; Moller HJ; Zias EA; Benhayon D; Fuster V; Moreno PR
Circ Res; 2007 Jul; 101(1):106-10. PubMed ID: 17525367
[TBL] [Abstract][Full Text] [Related]
39. Effects of storage conditions on the stability of serum CD163, NGAL, HMGB1 and MIP2.
Wang J; Zhu HH; Xue JH; Wu SS; Chen Z
Int J Clin Exp Pathol; 2015; 8(4):4099-105. PubMed ID: 26097598
[TBL] [Abstract][Full Text] [Related]
40. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.
Baeten D; Møller HJ; Delanghe J; Veys EM; Moestrup SK; De Keyser F
Arthritis Rheum; 2004 May; 50(5):1611-23. PubMed ID: 15146432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
